TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A bioRxiv preprint reports that ovarian tissue continues to show molecular changes decades after menopause. Researchers analyzed 28 ovaries and found age-associated protein patterns linked to inflammation, tissue remodeling and cellular signaling; the study is preliminary and does not establish health effects.
A preliminary study of 28 ovaries found age-related protein changes in tissue from women aged 50 to 75, suggesting the ovaries continue to undergo molecular remodeling long after menopause. The work, posted on bioRxiv and not yet peer-reviewed, points to changes associated with inflammation, tissue structure and cellular signaling, but does not show that those changes cause health problems.
Researchers examined histologically normal ovarian tissue from 28 women, grouped by age: 11 aged 50–59, 10 aged 60–69 and seven aged 70 or older. Using mass spectrometry, they measured 5,812 protein groups and compared their abundance across the age groups. The study focused on protein patterns in tissue, not on clinical outcomes or the women’s health over time.
Compared with the 50–59 group, the 60–69 group had significant changes in 40 protein groups: 34 were higher and six lower. The comparison between women aged 70 or older and the youngest group found changes in 117 protein groups, with 84 lower and 33 higher. The higher-abundance proteins included some linked to immune responses, inflammation and tissue remodeling; many of the lower-abundance proteins were associated with maintaining ovarian cell and tissue structure.
The investigators also identified 17 proteins altered in both age comparisons and assembled a proposed 26-protein aging signature, named the Buck Postmenopausal Ovary Molecular Signature, or BuckPOMS. The authors report that the overall pattern shifts from structural and epithelial-associated processes toward extracellular tissue remodeling and signaling. The model’s ability to distinguish the youngest from oldest group was described as moderate, and differences between adjacent age groups were more modest.
What Ovarian Aging Could Reveal
The findings challenge a longstanding view of the postmenopausal ovary as largely inactive tissue. They suggest that molecular activity continues after reproductive function ends, providing researchers with possible leads for studying how aging ovaries change and how those changes relate to health in later life.
That question matters because many women live for decades after menopause, while age is also associated with conditions including cardiovascular disease, osteoporosis and ovarian cancer. The study does not establish a connection between its protein findings and any of those conditions. Its value at this stage is in mapping patterns that later research can test, rather than offering a clinical explanation or guidance.
The proposed BuckPOMS signature may give future studies a set of proteins to investigate across larger and more diverse groups. If validated, such work could help clarify whether particular ovarian changes are ordinary features of aging, linked to other processes in the body, or associated with disease. Those possibilities remain open questions.
As an affiliate, we earn on qualifying purchases.
How Researchers Studied Older Ovaries
Menopause marks the end of menstrual cycles and reproductive years, as the supply of eggs declines with age. Ovaries are also known to change over time, but much prior research on ovarian aging has involved small samples or focused on women before or around menopause. The preprint says there has been less research on ovarian tissue across the decades that follow.
Earlier work has reported age-related changes in ovarian gene activity involving metabolism, cellular stress and communication between cells. The new study adds a protein-level analysis of postmenopausal tissue. Proteins carry out many cellular functions, but measuring differences in their abundance alone cannot show what caused those differences or what they mean for a person’s health.
The researchers used data-independent acquisition mass spectrometry with parallel accumulation-serial fragmentation, a method for measuring proteins in tissue samples. They compared groups at different ages rather than following the same individuals over time. That design can identify associations with age, but it cannot establish how an individual ovary changes as its owner grows older.
“The report is preliminary and has not been peer-reviewed.”
— The bioRxiv preprint notice
As an affiliate, we earn on qualifying purchases.
Limits of the Preprint Findings
The work is a non-peer-reviewed preprint, so its methods and conclusions have not yet undergone journal peer review. The sample was small—28 tissue donors—and the oldest age group included seven women. The findings may not represent the range of ovarian aging across the wider population.
The study reports associations between age groups, not proof that age alone caused the protein differences. It also does not establish whether the observed patterns affect hormone production, symptoms, disease risk or overall health. Tissue classified as histologically normal does not answer whether the molecular signatures predict later illness.
Further questions include whether the BuckPOMS signature can be reproduced in independent samples, how it varies among individuals, and whether the protein changes correspond to measurable effects in the body. The available report does not provide evidence that the findings should change screening or treatment.
hormone balance supplements for menopause
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Validation Before Health Applications
The immediate next step is peer review and independent replication. Larger studies could test whether the reported protein patterns recur in additional postmenopausal ovarian samples and assess how factors such as age and health history affect the results.
Researchers would also need to connect tissue-level protein changes to clinical data before drawing conclusions about disease risk or other health outcomes. Until such evidence is available, the study should be read as an early map of possible ovarian changes—not as a diagnosis, a prediction for an individual, or a basis for medical decisions.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the study find?
It found age-associated differences in ovarian protein levels among tissue samples from women aged 50 to 75. Some patterns were linked to inflammation and tissue remodeling, while many proteins associated with tissue structure were lower in the oldest group.
Does this prove ovaries remain active after menopause?
The study supports the idea that postmenopausal ovarian tissue continues to show molecular changes. It does not establish how those changes affect hormone production or health, and the findings remain preliminary.
Does the study show that ovarian changes cause disease?
No. The researchers compared proteins in tissue samples and did not demonstrate that the differences cause ovarian cancer or other health conditions.
Can the findings guide medical care now?
No. The report is a preprint that has not been peer-reviewed and is not evidence for changing screening, treatment or other health decisions. People with medical questions should consult a qualified health professional.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
